NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$27.82
Price · Aug 19, 2026
Fundamentals as of Aug 5, 2026
52W Range
$23–$42
25% of range
Analyst Rating
BUY
23 analysts
Price Target
$51
+84% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

NAMS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$27.82
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$23 – $42

NAMS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NAMS
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NAMS
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NAMS
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NAMS
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NAMS
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NAMS
Peer Median

NAMS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 23 analysts
  • Strong Buy 9 39.1%
  • Buy 12 52.2%
  • Hold 2 8.7%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

15 analysts · 2026-08-13
Median target $51.92 +86.6%
Mean target $51.28 +84.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.03%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.52 $-0.50 -0.02%
March 31, 2026 $-0.40 $-0.50 0.10%
Dec. 31, 2025 $-0.62 $-0.39 -0.23%
Sept. 30, 2025 $-0.61 $-0.40 -0.21%
June 30, 2025 $-0.15 $-0.50 0.35%
March 31, 2025 $-0.34 $-0.50 0.16%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Balance Sheet 16
Annual Balance Sheet data for NAMS
Metric Trend 2025
Cash & Equivalents $490M
Short-term Investments $146M
Prepaid Expense $38M
Current Assets $676M
PP&E (Net) $383.0K
Total Assets $769M
Accounts Payable $9M
Current Liabilities $86M
Capital Leases $66.0K
Total Liabilities $86M
Common Stock $14M
Retained Earnings $-762M
AOCI $5M
Stockholders' Equity $683M
Liabilities + Equity $769M
Shares Outstanding 114,399,326

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 221 filers · $3.5B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
58 (+35 vs prior Q) 17 (-19 vs prior Q) 67 (+2 vs prior Q) 52 (+3 vs prior Q) -1.7M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Frazier Life Sciences Management, L.P. $613,032,889 18,088,902 17.71% Shares
Capital World Investors $414,493,577 12,230,557 11.97% Shares
RA CAPITAL MANAGEMENT, L.P. $323,655,973 9,550,191 9.35% Shares
FMR LLC $230,928,731 6,814,067 6.67% Shares
FCPM III SERVICES B.V. $157,521,567 4,648,025 4.55% Shares
DEERFIELD MANAGEMENT COMPANY, L.P. $144,533,699 4,264,789 4.18% Shares
VIKING GLOBAL INVESTORS LP $142,458,886 4,203,567 4.12% Shares
Bain Capital Life Sciences Investors, LLC $129,004,522 3,806,566 3.73% Shares
MAVERICK CAPITAL LTD $110,745,810 3,267,802 3.20% Shares
Medicxi Ventures Management (Jersey) Ltd $74,850,776 2,208,639 2.16% Shares
JENNISON ASSOCIATES LLC $64,539,573 1,904,384 1.86% Shares
Polar Capital Holdings Plc $58,443,915 1,724,518 1.69% Shares
Capital International Investors $58,409,246 1,723,495 1.69% Shares
GOLDMAN SACHS GROUP INC $52,357,034 1,544,911 1.51% Shares
WESTFIELD CAPITAL MANAGEMENT CO LP $52,071,036 1,536,472 1.50% Shares
Castle Hook Partners LP $46,463,359 1,371,005 1.34% Shares
AMERIPRISE FINANCIAL INC $40,612,057 1,198,346 1.17% Shares
ALLIANCEBERNSTEIN L.P. $40,330,679 1,259,940 1.17% Shares
Aberdeen Group plc $37,373,384 1,102,785 1.08% Shares
FRANKLIN RESOURCES INC $28,662,896 845,763 0.83% Shares
JPMORGAN CHASE & CO $28,157,113 831,329 0.81% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $25,564,142 754,327 0.74% Shares
Woodline Partners LP $25,501,852 752,489 0.74% Shares
TimesSquare Capital Management, LLC $24,071,136 751,988 0.70% Shares
AMERICAN CENTURY COMPANIES INC $23,208,343 684,813 0.67% Shares
BANK OF AMERICA CORP /DE/ $22,212,319 655,424 0.64% Shares
Jefferies Financial Group Inc. $20,334,000 600,000 0.59% Put option
Rock Springs Capital Management LP $19,749,194 582,744 0.57% Shares
First Turn Management, LLC $19,740,823 582,497 0.57% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $19,269,854 568,600 0.56% Put option
ADAGE CAPITAL PARTNERS GP, L.L.C. $18,639,500 550,000 0.54% Shares
Artia Global Partners LP $17,078,391 503,936 0.49% Shares
MILLENNIUM MANAGEMENT LLC $16,999,698 501,614 0.49% Shares
PERCEPTIVE ADVISORS LLC $16,945,000 500,000 0.49% Put option
Cormorant Asset Management, LP $16,945,000 500,000 0.49% Shares
KENNEDY CAPITAL MANAGEMENT LLC $14,280,365 421,374 0.41% Shares
Slate Path Capital LP $10,810,910 319,000 0.31% Shares
ExodusPoint Capital Management, LP $10,313,879 304,334 0.30% Shares
Eversept Partners, LP $9,335,712 275,471 0.27% Shares
Affinity Asset Advisors, LLC $9,319,750 275,000 0.27% Shares
SEB Asset Management AB $9,240,226 272,654 0.27% Shares
Atle Fund Management AB $8,433,458 248,848 0.24% Shares
CITADEL ADVISORS LLC $7,951,102 234,615 0.23% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $7,791,684 229,911 0.23% Shares
GILDER GAGNON HOWE & CO LLC $7,593,732 224,070 0.22% Shares
LMR Partners LLP $7,269,405 214,500 0.21% Put option
Ensign Peak Advisors, Inc $7,199,015 212,423 0.21% Shares
ArrowMark Colorado Holdings LLC $7,179,359 211,843 0.21% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $6,156,932 181,674 0.18% Shares
Decheng Capital LLC $5,994,700 176,887 0.17% Shares
WELLINGTON MANAGEMENT GROUP LLP $5,883,609 173,609 0.17% Shares
VICTORY CAPITAL MANAGEMENT INC $5,851,549 172,663 0.17% Shares
PEREGRINE CAPITAL MANAGEMENT LLC $5,743,948 169,488 0.17% Shares
Point72 Asset Management, L.P. $5,724,055 168,901 0.17% Shares
AXA Investment Managers S.A. $5,596,480 196,782 0.16% Shares
Mizuho Markets Cayman LP $5,101,767 150,539 0.15% Shares
TD Asset Management Inc $5,029,276 148,400 0.15% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $5,015,720 148,000 0.14% Call option
XTX Topco Ltd $4,914,321 145,008 0.14% Shares
DCF Advisers, LLC $4,778,490 141,000 0.14% Shares
KORNITZER CAPITAL MANAGEMENT INC /KS $4,742,329 139,933 0.14% Shares
Cutter Capital Management, LP $4,526,981 221,152 0.13% Shares
Bank of New York Mellon Corp $4,442,200 131,077 0.13% Shares
Jefferies Financial Group Inc. $4,159,252 122,728 0.12% Shares
BOOTHBAY FUND MANAGEMENT, LLC $4,107,468 121,200 0.12% Put option
Swiss National Bank $4,104,079 121,100 0.12% Shares
D. E. Shaw & Co., Inc. $4,085,812 120,561 0.12% Shares
ADAR1 Capital Management, LLC $4,020,133 118,623 0.12% Shares
ALPS ADVISORS INC $4,003,934 118,145 0.12% Shares
STATE STREET CORP $3,904,636 115,215 0.11% Shares
Walleye Capital LLC $3,789,546 111,819 0.11% Shares
GEODE CAPITAL MANAGEMENT, LLC $3,562,287 105,169 0.10% Shares
Swedbank AB $3,527,949 104,100 0.10% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $3,261,302 96,232 0.09% Shares
Caption Management, LLC $3,124,658 92,200 0.09% Put option
Squarepoint Ops LLC $3,118,761 92,026 0.09% Shares
Moody Aldrich Partners LLC $3,071,010 90,617 0.09% Shares
Schonfeld Strategic Advisors LLC $3,042,135 89,765 0.09% Shares
Bellevue Group AG $2,948,227 86,994 0.09% Shares
ALGERT GLOBAL LLC $2,756,613 81,340 0.08% Shares
Man Group plc $2,739,396 80,832 0.08% Shares
TUDOR INVESTMENT CORP ET AL $2,692,899 79,460 0.08% Shares
Y-Intercept (Hong Kong) Ltd $2,648,029 78,136 0.08% Shares
STEMPOINT CAPITAL LP $2,629,491 77,589 0.08% Shares
Headlands Technologies LLC $2,451,433 72,335 0.07% Shares
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main $2,145,169 63,298 0.06% Shares
FOX RUN MANAGEMENT, L.L.C. $2,015,675 59,477 0.06% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $1,739,071 54,329 0.05% Shares
China Universal Asset Management Co., Ltd. $1,647,223 48,605 0.05% Shares
Qube Research & Technologies Ltd $1,595,880 47,090 0.05% Shares
FRED ALGER MANAGEMENT, LLC $1,528,947 45,115 0.04% Shares
Palo Alto Investors LP $1,503,327 44,359 0.04% Shares
Knights of Columbus Asset Advisors LLC $1,484,382 43,800 0.04% Shares
FIRST TRUST ADVISORS LP $1,460,930 43,108 0.04% Shares
VANGUARD ASSET MANAGEMENT, Ltd $1,437,682 42,422 0.04% Shares
Fieldview Capital Management, LLC $1,418,025 41,842 0.04% Shares
CITADEL ADVISORS LLC $1,301,376 38,400 0.04% Call option
Ishara Investments LP $1,250,541 36,900 0.04% Shares
BOOTHBAY FUND MANAGEMENT, LLC $1,211,771 35,756 0.04% Shares
BNP PARIBAS FINANCIAL MARKETS $1,210,212 35,710 0.03% Shares

Company insiders 15 insiders · 8 officers · 8 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Michael H. Davidson Chief Executive Officer March 2, 2026 M 174,144 0 8 $-25,328,350
Mayur Ian Somaiya Chief Financial Officer Jan. 21, 2026 M 58,382 0 6 $-3,430,793
Douglas F Kling Chief Operating Officer July 16, 2025 M 44,000 0 0 $0
Louise Frederika Kooij Chief Accounting Officer May 26, 2026 M 24,353 0 15 $-16,889,343
Johannes Jacob Pieter Kastelein Chief Scientific Officer March 9, 2026 M 69,302 0 9 $-13,368,006
Michael F Marino III Chief Legal Officer and Corporate Secretary June 1, 2025 A 55,000 0 0 $0
Juliette Berangere Audet Chief Strategy and Business Officer May 1, 2025 A 15,104 0 0 $0
William A Jones JR Chief Commercial Officer Jan. 7, 2025 A 43,000 0 0 $0
Louis G Lange Director March 11, 2026 S 10,360 0 3 $-2,186,180
Hilde Johanna Van Der Kamp Director Jan. 7, 2026 A 10,360 0 0 $0
Mark C. Mckenna Director Jan. 7, 2026 A 10,360 0 0 $0
Adele M. Gulfo Director Jan. 7, 2026 A 14,260 0 0 $0
John W Smither Director Jan. 7, 2026 A 10,360 0 0 $0
William Lewis Director Jan. 7, 2026 A 10,360 0 0 $0
James N. Topper — Sept. 15, 2025 P 3,028,524 1 0 $15,642

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
BCLS Fund III Investments, LP, Bain Capital Life Sciences Opportunities III, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCLS II Equity Opportunities, LP, BCIP Life Sciences Associates, LP ×6 filings Dec. 4, 2025 4.70% Amendment — SEC
Frazier Life Sciences X, L.P., Frazier Lifesciences Sponsor LLC, FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×2 filings Nov. 4, 2025 7.70% Amendment — SEC
Forbion Capital Fund IV Cooperatief U.A., Forbion IV Management B.V., Forbion Growth Opportunities Fund I Cooperatief U.A., Forbion Growth Management B.V., ForGrowth NAP B.V. ×2 filings Sept. 30, 2025 8.30% Amendment — SEC
Forbion Capital Fund IV Coöperatief U.A., Forbion IV Management B.V., Forbion Growth Opportunities Fund I Coöperatief U.A., Forbion Growth Management B.V., ForGrowth NAP B.V. ×4 filings Dec. 17, 2024 — Initial filing — SEC
Frazier Lifesciences Sponsor LLC, Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×5 filings Dec. 17, 2024 — Initial filing — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 8 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
SBIO · ALPS ETF Trust 2.47% 118,514 NS May 31, 2026 N-PORT
GURU · Global X Funds 0.87% 17,865 NS April 30, 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0.22% 6,363 SH Aug. 8, 2026 Daily
IBB · iShares Trust 0.17% 589,990 SH Aug. 8, 2026 Daily
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.09% 19,307 NS May 31, 2026 N-PORT
ESML · iShares Trust 0.04% 40,058 SH Aug. 8, 2026 Daily
VHT · VANGUARD WORLD FUND 0.03% 181,674 SH Aug. 8, 2026 Daily
WSML · iShares Trust 0.02% 3,695 SH Aug. 8, 2026 Daily